News

Teladoc (TDOC) shares are inching up after Citron Research likened them to a “coiled spring” – full of potential, compressed, ...
I maintain my Buy rating on Teladoc Health due to positive acquisitions and a robust balance sheet, despite recent weak Q1 ...
Teladoc (TDOC) shares rallied 14.4% in the last trading session to close at $7.89. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session ...
Teladoc Health (TDOC) stock rallies as Citron Research issues a bullish report on the company. Read more here.
Teladoc Health Inc (NYSE:TDOC) shares are rising Monday after Citron Research made positive comments about the company on its ...